Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.
from NDTV News - Latest https://ift.tt/3x0xVOe
from NDTV News - Latest https://ift.tt/3x0xVOe
Comments
Post a Comment